Stage I endometrial adenocarcinoma: treatment results in 835 patients - PubMed (original) (raw)
Comparative Study
Stage I endometrial adenocarcinoma: treatment results in 835 patients
R J Lotocki et al. Am J Obstet Gynecol. 1983.
Abstract
A 16-year review of 835 patients with Stage I adenocarcinoma of the uterus revealed histologic grade and depth of myometrial invasion to be salient prognostic factors. Sixteen percent of patients developed recurrent disease and despite aggressive treatment, only 10% of these survived. Preoperative or postoperative radium decreased the incidence of vault recurrence.
Similar articles
- Adenocarcinoma of the endometrium stage I. Treatment, survival and recurrence.
Philipsen T, Nørgård M. Philipsen T, et al. Acta Obstet Gynecol Scand. 1984;63(1):51-5. doi: 10.3109/00016348409156273. Acta Obstet Gynecol Scand. 1984. PMID: 6720256 - Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
De Palo G, Kenda R, Andreola S, Luciani L, Musumeci R, Rilke F. De Palo G, et al. Obstet Gynecol. 1982 Aug;60(2):225-31. Obstet Gynecol. 1982. PMID: 7155485 - Risk factors and recurrent patterns in Stage I endometrial cancer.
DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. DiSaia PJ, et al. Am J Obstet Gynecol. 1985 Apr 15;151(8):1009-15. doi: 10.1016/0002-9378(85)90371-0. Am J Obstet Gynecol. 1985. PMID: 3985062 - Treatment of adenocarcinoma of the endometrium.
Jones HW 3rd. Jones HW 3rd. Obstet Gynecol Surv. 1975 Mar;30(3):147-69. doi: 10.1097/00006254-197503000-00001. Obstet Gynecol Surv. 1975. PMID: 1091895 Review. - Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ, Elshaikh MA, Ali-Fehmi R, Haley MM, Yoon J, Mahan M, Munkarah AR. Jalloul RJ, et al. Int J Gynecol Cancer. 2012 Jun;22(5):812-8. doi: 10.1097/IGC.0b013e31824aa877. Int J Gynecol Cancer. 2012. PMID: 22569105 Review.
Cited by
- The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer.
Jia M, Pi J, Zou J, Feng M, Chen H, Lin C, Yang S, Xiao X. Jia M, et al. Cancer Control. 2023 Jan-Dec;30:10732748231206929. doi: 10.1177/10732748231206929. Cancer Control. 2023. PMID: 37924202 Free PMC article. - Effect of Pelvic Lymphadenectomy on Survival in Patients with Low-Risk Early-Stage Endometrial Cancer Diagnosed Intraoperatively Using Frozen Tissue Sections: A Retrospective Analysis.
Liu C, Zhao J, Liu S, Ma Y, Yang Y, Qu P. Liu C, et al. Cancer Manag Res. 2020 Oct 29;12:10715-10723. doi: 10.2147/CMAR.S274992. eCollection 2020. Cancer Manag Res. 2020. PMID: 33149678 Free PMC article. - Small interfering RNA-mediated knockdown of Twist attenuates the aggressive phenotypes of human endometrial carcinoma Ishikawa cells.
Pan Y, Liu X, Huang Y. Pan Y, et al. Exp Ther Med. 2017 Dec;14(6):5647-5651. doi: 10.3892/etm.2017.5214. Epub 2017 Sep 27. Exp Ther Med. 2017. PMID: 29285105 Free PMC article. - MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.
Wang Y, Hu L, Ji P, Teng F, Tian W, Liu Y, Cogdell D, Liu J, Sood AK, Broaddus R, Xue F, Zhang W. Wang Y, et al. J Hematol Oncol. 2016 Oct 19;9(1):112. doi: 10.1186/s13045-016-0342-6. J Hematol Oncol. 2016. PMID: 27760566 Free PMC article. - MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S, Sun KX, Liu BL, Zong ZH, Zhao Y. Chen S, et al. Mol Cancer. 2016 Feb 2;15:11. doi: 10.1186/s12943-016-0496-4. Mol Cancer. 2016. PMID: 26832151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical